Business Standard

US drug regulator inspects Sun Pharmaceutical's Halol plant in Gujarat

Sun Pharma had recalled around 5,000 units of 10 ml vials of testosterone cypionate injections from the US

Sun Pharma
Premium

Sohini Das Mumbai
Sun Pharmaceutical Industries’ Halol plant in Gujarat, which was cleared in June by the US drug regulator, has been undergoing a fresh inspection, sources claimed. 

The company declined to comment on the matter. Analysts said that while it could be a surprise audit (given the plant’s history of regulatory issues), it could also be a pre-approval inspection (that usually happens before a product from that site is approved by the US drug regulator). Sources claimed a team of inspectors from the US Food and Drug Administration (USFDA) was at the facility to inspect the plant.  

The company stock was down
Topics : Sun Pharma

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in